Furthermore, TGF-β markedly suppressed the ‘cytotoxic program' of cytotoxic T lymphocytes, which have been shown that favor tumor progression (Thomas and Massague, 2005; Yang et al., 2010). This evidence concerns the gene TGFB1 and neoplasm.